EN
More
Shenzhen headquarters
14th floor, Block A, Jinxiu Phase III, No. 85 Hudipai, Songxuan Community, Guanhu Town, Longhua District, Shenzhen, Guangdong Province, China
關(guān)于我們
ABOUT US
COMPANY PROFILE
Company Profile
Shenzhen Qinglan Biotechnology Co., Ltd. is a high-tech R&D-driven enterprise focusing on soluble microneedle drug delivery, providing a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world.
Jiang Lin, the founder of the company, is the Doctor of Organic Chemistry from Chinese Academy of Sciences, and the leader in the research and development of transdermal drug delivery technology and industrialization of soluble microneedle. He has obtained more than 40 national patents for inventions. The core R&D personnel of the team of Dr. Jiang Lin are composed of doctors and masters with medical, pharmaceutical, and chemical backgrounds, they have been committed to the research of microneedle transdermal drug delivery, take the lead in realizing the research and development and production of microneedle for innovative drugs.
BIOQINGLAM, which has been established less than three years ago, has completed two rounds of financing and is currently conducting A round of financing. The company has cooperated with several well-known pharmaceutical companies, and in 2022, the company signed the first microneedle CRO contract in China. At present, many companies are negotiating microneedle business cooperation with BIOQINGLAM, and we are expected to achieve the first IND of microneedle drugs in the next two years.
As a leader in dissolvable microneedle technology, BIOQINGLAM is committed to providing customers with multi-faceted, customized, differentiated services and drug delivery solutions for dissolvable microneedle drug delivery CRO, CMO, and CDMO services to meet the needs of our pharmaceutical partners from preclinical process development to the end of commercial production.
"It starts small."
Jiang Lin, the founder of the company, is the Doctor of Organic Chemistry from Chinese Academy of Sciences, and the leader in the research and development of transdermal drug delivery technology and industrialization of soluble microneedle. He has obtained more than 40 national patents for inventions. The core R&D personnel of the team of Dr. Jiang Lin are composed of doctors and masters with medical, pharmaceutical, and chemical backgrounds, they have been committed to the research of microneedle transdermal drug delivery, take the lead in realizing the research and development and production of microneedle for innovative drugs.
BIOQINGLAM, which has been established less than three years ago, has completed two rounds of financing and is currently conducting A round of financing. The company has cooperated with several well-known pharmaceutical companies, and in 2022, the company signed the first microneedle CRO contract in China. At present, many companies are negotiating microneedle business cooperation with BIOQINGLAM, and we are expected to achieve the first IND of microneedle drugs in the next two years.
As a leader in dissolvable microneedle technology, BIOQINGLAM is committed to providing customers with multi-faceted, customized, differentiated services and drug delivery solutions for dissolvable microneedle drug delivery CRO, CMO, and CDMO services to meet the needs of our pharmaceutical partners from preclinical process development to the end of commercial production.
"It starts small."
BIOQINGLAM will be the leader in the field of microneedle drug delivery.
-
2020Founded in 2020
-
40+More than 40 patents for invention
-
3000+Plant area of more than 3000 square meters
R&D TEAM
R&D TEAM
-
Lin JiangFounder of the Company / Doctor of Organic Chemistry, Chinese Academy of SciencesHe is the founder of the company, doctor of organic chemistry from Chinese Academy of Sciences, leader of research and development and industrialization of transdermal drug delivery technology of soluble microneedles, and the founder, executive director and general manager of Shenzhen Qinglan Biotechnology Co., Ltd., and has obtained more than 40 national authorized invention patents. He focuses on the research and development on microneedle delivery vaccine and the solutions for new drug research and development of microneedle patches.More
-
Xingyou LiQuality Operation DirectorBachelor of Science in Analytical Chemistry, Department of Chemistry, Jilin University.More
He has set up 3 testing laboratories and participated in the hardware and GMP software construction of 3 pharmaceutical enterprises. He has 16 years of laboratory experience and 22 years of quality management experience in the pharmaceutical industry. Involving ISO 9001 certification, CNAS accreditation, WHO-PQ certification, GMP certification at home and abroad, etc., he has rich experience in GMP auditing.
Many years of experience in biological products, traditional Chinese medicine preparations, chemical preparations and other fields. The pharmaceutical dosage forms involved are: sterile lyophilized powder injection, small volume injection, tablets, capsules, soft capsules, granules, etc.
Participated in the quality research of multiple biologics projects and obtained two drug clinical research approvals.
Organized and completed two drug production technology transfer projects, and obtained 6 drug supplement application approvals. -
Venus PoonR&D DirectorShe has more than ten years experience in the R&D, registration, and management of new drug preparations, she has been responsible for and managed drug research and development and registration from innovative drug preparation research and development, the declaration to full life cycle management in several pharmaceutical companies.More
Familiar with the R&D, application, and registration requirements of innovative drug preparations, also familiar with the registration requirements of biopharmaceutical IND and BLA. Has been responsible for the development, quality research, and registration application of a number of innovative drug preparations.
Serving as the company's R&D director, responsible for the company's R&D of new drug preparation, and quality research.
Lin Jiang
Xingyou Li
Venus Poon
ENTERPRISE DISPLAY
Enterprise Show
OUR HONOR
Certificate of Honor
INVESTORS
Financing History
JUL 2021 Received 10 million yuan (angel round) investment from Beijing Advaccine Biotechnology Co., Ltd.
JUL 2022 Led by Jiaxing TianfuHuasheng Equity Investment Partnership (Limited Partnership), followed by Beijing Advaccine Biotechnology Co., Ltd., received a total of 25 million yuan (pre-A round) investment.
JUN 2023 A round of financing (the 3rd round)
CONTACT US
Contact Us
-
-
Factory addressRoom 901, Building No. 3, Yinxing Zhijie Phase I, Longhua District, Shenzhen, Guangdong Province, China
-
Tel.0755-21013290 -
Emailbioqinglam@bioqinglam.com
